OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Hematology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis	71
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia	49
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis	47
Hormetic endoplasmic reticulum stress in hematopoietic stem cells	24
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies	23
Deficits in our understanding of natural killer cell development in mouse and human	21
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective	20
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function	19
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy	17
Mechanisms of immunothrombosis in COVID-19	17
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis	16
Developmental regulation of primitive erythropoiesis	16
Disparities in acute myeloid leukemia treatments and outcomes	16
Mesenchymal stromal cells: an update	16
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications	15
Platelet lifespan and mechanisms for clearance	15
The impact of obesity-induced inflammation on clonal hematopoiesis	14
Congenital neutropenia: disease models guiding new treatment strategies	13
Unraveling lipid metabolism for acute myeloid leukemia therapy	12
The new world: hematopoietic stem cell transplant during a pandemic	12
Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation	12
Editorial introductions	11
High-throughput genotyping tools for red blood cell antigens	11
Editorial introductions	11
Advances on the genetic basis of red cell membrane disorders	10

Abnormal monocyte differentiation and function in chronic myelomonocytic leukemia	10
Humanized murine models of platelet function	10
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration	9
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential	9
Multifaceted roles of CRISPR technology in blood cancer research	9
Targeting the cluster of differentiation 47/signal-regulatory protein alpha axis in myeloid malignancies	8
Editorial introduction	8
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation	8
Red cells: not only hemoglobin – plasma membranes are also of paramount importance	7
Editorial introductions	7
Editorial introductions	7
Platelets in vascular inflammation: fire-fighters or pyromaniacs?	7
Red blood cell changes due to cancer and cancer treatments: a narrative review	7
Targeting hemostatic enzymes: from mechanistic insights to therapeutic frontiers	7
Hemostatic abnormalities in acute promyelocytic leukemia: clinical implications and mechanisms	7
Understanding and targeting erythroid progenitor cells for effective cancer therapy	7
Venous thromboembolism: diagnostic advances and unaddressed challenges in management	6
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells	6
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	6
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology	6
The immunology of PF4 polyanion interactions	6
Chediak-Higashi syndrome	6
Current Opinion in Hematology	6
Modelling arterial thrombus formation in vitro	6
Models to study myelodysplastic syndrome and acute myeloid leukaemia	5
PROTACs in platelets: emerging antithrombotic strategies and future perspectives	5
The state of prediction models in hematologic disease: a worrisome assessment	5
Translation defects in ribosomopathies	5
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease	5
Platelet transfusion	5
Donor selection in allogeneic stem cell transplantation	4
Immunomodulatory roles of red blood cells	4
Recent advances in factor XII structure and function	4
Switching and increasing prophylaxis regimen with a genetically recombinant fusion of coagulation factor IX and albumin in haemophilia B: a case report	4
The congenital dyserythropoieitic anemias: genetics and pathophysiology	4
Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices	4
The fulfilled promise and unmet potential of umbilical cord blood	4
Platelets and platelet–leukocyte interactions in infectious diseases	4
Editorial introductions	4
Novel approaches to measure transfusion effectiveness	4
Editorial introduction	4
Editorial introduction	4
Platelet mitochondria: the mighty few	4
No time to die? Intrinsic apoptosis signaling in hematopoietic stem and progenitor cells and therapeutic implications	4
Azacitidine maintenance in AML post induction and posttransplant	4
Epigenetics of hematopoietic stem cell aging	3
Red cell extracellular vesicles and coagulation activation pathways	3
Age-related micro-environmental changes as drivers of clonal hematopoiesis	3
Scoring systems to predict thrombotic complications in solid tumor patients	3
Immunologic effects of red blood cell and platelet transfusions in neonates	3

Editorial introduction	3
Proteome remodeling and organelle clearance in mammalian terminal erythropoiesis	3
The impact of prenatal inflammation on hematopoietic development	3
Pediatric acute myeloid leukemia – novel approaches	3
Editorial introduction	3
Macrocytic anemias	3
Germline DDX41 mutations in myeloid neoplasms: the current clinical and molecular understanding	3
Hematopoietic stem cell collection for sickle cell disease gene therapy	3
Role of ATP-dependent chromatin remodelers in hematopoietic stem and progenitor cell maintenance	3
Editorial Introductions	2
Direct megakaryopoiesis	2
Iron status of blood donors	2
Detecting and preventing post-hematopoietic cell transplant relapse in AML	2
Advances in chimeric antigen receptor-T therapies to target tumor resistance in B-cell malignancies	2
Circulating platelet count and glycans	2
Factor XI as a therapeutic target in neuroinflammatory disease	2
Clinical experience of coronavirus disease 2019 in hematopoietic cell transplant and chimeric antigen receptor T-cell recipients	2
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia	2
Platelet Fc gamma RIIA: time to go beyond the unknown	2
The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease	2
Emerging functional microfluidic assays for the study of thromboinflammation in sickle cell disease	2
Clonal hematopoiesis of indeterminate potential: recent developments and perspectives	2
Editorial introduction	2
Histological differences among thrombi in thrombotic diseases	2
Alteration of interleukin-10-producing Type 1 regulatory cells in autoimmune diseases	2
N6-methyladenosine in hematological malignancies: a concise review	2
Crosstalk between terminal erythropoiesis and granulopoiesis within their common niche: the erythromyeloblastic island	2
PIEZO1, sensing the touch during erythropoiesis	2
The interplay between physical and mental health and its impact on outcomes for hemopoietic stem cell transplant patients	2